A Phase 1/2 Open-Label Study to Evaluate the Safety, Tol

Project: Research project

Project Details

Description

A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of VT-464 in Patients with Advanced Breast Cancer.
StatusFinished
Effective start/end date2/1/165/22/19

Funding

  • INNOCRIN PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.